| ORIGINAL ARTICLE |
|
| Year : 2009 | Volume
: 52
| Issue : 4 | Page : 482-485 |
|
|
HER-2/neu expression in lesions of uterine cervix: Is it reliable and consistent?
Nidhi Gupta, Sunita Singh, Nisha Marwah, Sanjay Kumar, Sonia Chabra, Rajeev Sen
Department of Pathology, Post Graduate Institute of Medical Sciences, Rohtak-124 001, Haryana, India
Correspondence Address:
Sanjay Kumar
4\9J, Medical Enclave, PGIMS, Rohtak-124 001, Haryana
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0377-4929.56127
|
|
|
This study was conducted to evaluate the expression of HER-2/neu oncogene in the lesions of the uterine cervix and to determine its correlation with histological type of malignancy, grade and clinical stage of presentation. One hundred cervical specimens were included in this study. These comprised cases with diagnosis of benign epithelial lesions, squamous cell carcinoma, adenocarcinoma, carcinoma cervix with glandular differentiation and cervical intraepithelial neoplasia. HER-2/neu immunostaining was performed by streptovidin-biotin peroxidase method. Higher expression of HER-2/neu was noted in malignant lesions as compared to benign lesions. Intensity of staining also correlated with clinical stage of presentation, lymph node metastasis and presence of parametrial extension. The over-expression of HER-2 oncoprotein is associated with poor prognosis, metastatic potential and aggressive biological behavior. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
